Avalyn Pharma Inc. Common Stock (AVLN) — Strategic Asset Allocation Index
Avalyn Pharma Inc. Common Stock (AVLN) has a Strategic Asset Allocation Index of 15.3% as of June 2026. Strategic assets (PP&E of $- plus long-term investments of $61.10 Million) total $61.10 Million, measured against net assets of $398.35 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See AVLN equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Annual Strategic Asset Allocation Index for Avalyn Pharma Inc. Common Stock (None–None)
The table below presents the year-by-year Strategic Asset Allocation Index for Avalyn Pharma Inc. Common Stock from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See shareholders equity of Avalyn Pharma Inc. Common Stock for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|